InjuryBoard Philadelphia Archives

• Black Box Warning for Reglan

  Jamie Sheller | March 31, 2009 8:53 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Reglan will soon get a boxed warning of the risks of long term and high dose use, as recently required by the FDA. Reglan is one of a group of drugs containing metoclopramide, which is used to treat...

• Recall of Male Enhancement Product

  Jamie Sheller | March 29, 2009 3:03 PM | 0 Comments
  Category: Defective & Dangerous Products

  Bodee LLC has advised customers to immediately stop using its product, Zencore Plus. The product is marketed as an herbal supplement that enhances male sexual performance. In recent FDA tests, it...

• Recall of External Defibrillators

  Jamie Sheller | March 29, 2009 2:02 PM | 0 Comments
  Category: Defective & Dangerous Products

  Welch Allyn Protocol voluntarily recalled more than 14,000 automatic external defibrillators. This action is a Class 1 recall, the most serious type, which is used when it is reasonably probable...

• Promotion of High-Dose Laxative Leads to Injuries

  Jamie Sheller | March 24, 2009 12:55 PM | 0 Comments
  Category: FDA & Prescription Drugs

  The maker of an oral laxative product faces lawsuits over its promotion of the product. Fleet Phospho-Soda is a laxative made by C. B. Fleet Co., Inc., which is headquarted in Lynchburg, Virginia....

• Newly Released Documents Raise More Questions Over Seroquel

  Jamie Sheller | March 23, 2009 2:04 PM | 0 Comments
  Category: FDA & Prescription Drugs

  In early 2000, Dr. S. Charles Schulz reported to a national medical conference that Seroquel was significantly superior to the old preferred schizophrenia treatment. Dr. Schulz is the chief of...

• FDA Gets Scolded By Public Citizen Over Baxter Pumps

  Jamie Sheller | March 18, 2009 12:22 PM | 1 Comments
  Category: Medical Devices & Implants

  The FDA has recently come under fire from a consumer watchdog group. Public Citizen expressed anger at the FDA for its delay in evaluating the latest problems with Baxter International's infusion...

• Product Letter From Baxter Receives FDA Severe Urgency Level

  Jamie Sheller | March 18, 2009 10:52 AM | 0 Comments
  Category: Medical Devices & Implants

  In January Baxter International issued a warning letter to customers regarding its Colleague Volumetric Infusion pumps. The pumps are used to deliver intravenous fluids and medicine to patients in...

• "Black Box" Warnings Ordered for Metoclopramide Drugs

  Jamie Sheller | March 12, 2009 6:59 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Some drugs used to treat gastrointestinal disorders will soon have a black box warning. A black box warning is the strongest warning that the FDA requires for drug labels. Metoclopramide is a drug...

• Supreme Court Says No to Implied Preemption

  Jamie Sheller | March 09, 2009 10:43 AM | 0 Comments
  Category: FDA & Prescription Drugs

  In a highly anticipated decision, the United States Supreme Court has ruled that drug manufacturers are not shielded from personal injury lawsuits by implied preemption. The case, Wyeth v. Levine,...

• Tainted Drywall Thought To Injure Homeowners

  Jamie Sheller | March 07, 2009 5:01 PM | 1 Comments
  Category: Defective & Dangerous Products

  A construction material, manufactured in China, is believed to be sickening homeowners in a number of states across the U.S. Sulfur-tainted drywall may have been installed in tens of thousands of...

• Serious Neurologic Disease Linked to Raptiva

  Jamie Sheller | March 05, 2009 2:32 PM | 0 Comments
  Category: FDA & Prescription Drugs

  In 2003, the FDA approved Raptiva as a treatment for moderate to severe plaque psoriasis. Raptiva (efalizumab) is manufactured by Genentech. Raptive works by suppressing the immune system, which...

• AstraZeneca's Hidden Information On Seroquel

  Jamie Sheller | March 04, 2009 3:16 PM | 0 Comments
  Category: FDA & Prescription Drugs

  AstraZeneca is being sued by thousands of people claiming that the company did not adequately warn about the risk of diabetes linked to its drug Seroquel. Documents unsealed in the consolidated...

• AstraZeneca Allegedly Buries Unfavorable Data About Seroquel

  Jamie Sheller | March 02, 2009 12:29 PM | 0 Comments
  Category: FDA & Prescription Drugs

  AstraZeneca, the maker of the antipsychotic drug Seroquel, is the defendant in a number of cases filed by over 9,000 people claiming that their use of Seroquel led to the development of diabetes....